Quantum Biopharma (QNTM) vs TherapeuticsMD (TXMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
TherapeuticsMD (TXMD) has outperformed Quantum Biopharma (QNTM) over the past year, gaining 89.6% versus a loss of 80.3%. Over five years, TXMD leads with a -94.4% price change compared with -96.7% for QNTM. TherapeuticsMD is the larger company by market cap ($23.1 million vs $19.8 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | QNTM | TXMD |
|---|---|---|
| Share price | $3.08 | $2.00 |
| Market cap | $19.80M | $23.15M |
| 1-day change | -0.96% | -0.50% |
| YTD return | -57.40% | +23.31% |
| 1-year return | -80.28% | +89.62% |
| 5-year return | -96.65% | -94.42% |
| Forward P/E | — | 5.71 |
| EPS (TTM) | $-4.98 | $-0.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $16.36 | $2.95 |
| 52-week low | $2.07 | $1.03 |
| Distance from 52-week high | -81.17% | -32.20% |
| Analyst consensus | none | — |
| Avg. price target upside | +298.38% | — |
| Average volume | 205.30K | 23.49K |
| Shares outstanding | 6.43M | 11.57M |
| Employees | — | 1 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TXMD has outperformed QNTM by 169.9 percentage points over the past year.
About Quantum Biopharma
QNTM stock →Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments.
Health Care · Biotechnology: Pharmaceutical Preparations
About TherapeuticsMD
TXMD stock →TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally.
Health Care · Biotechnology: Pharmaceutical Preparations · 1 employees
QNTM vs TXMD FAQ
Which is bigger, Quantum Biopharma or TherapeuticsMD?
TherapeuticsMD (TXMD) is larger, with a market capitalization of $23.15M compared with $19.80M for Quantum Biopharma (QNTM).
Which stock has performed better over the past year, QNTM or TXMD?
TXMD returned +89.62% over the past 12 months, compared with -80.28% for QNTM (price return, excluding dividends). Past performance does not predict future results.
Are Quantum Biopharma and TherapeuticsMD in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.